Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill (2016 - 2025)

Amphastar Pharmaceuticals has reported Goodwill over the past 13 years, most recently at $3.4 million for Q4 2025.

  • Quarterly results put Goodwill at $3.4 million for Q4 2025, up 11.58% from a year ago — trailing twelve months through Dec 2025 was $3.4 million (up 11.58% YoY), and the annual figure for FY2025 was $3.4 million, up 11.58%.
  • Goodwill for Q4 2025 was $3.4 million at Amphastar Pharmaceuticals, roughly flat from $3.4 million in the prior quarter.
  • Over the last five years, Goodwill for AMPH hit a ceiling of $3.8 million in Q2 2021 and a floor of $2.9 million in Q3 2022.
  • Median Goodwill over the past 5 years was $3.2 million (2023), compared with a mean of $3.3 million.
  • Biggest five-year swings in Goodwill: dropped 20.47% in 2022 and later grew 11.58% in 2025.
  • Amphastar Pharmaceuticals' Goodwill stood at $3.3 million in 2021, then dropped by 5.64% to $3.1 million in 2022, then grew by 2.88% to $3.2 million in 2023, then fell by 5.19% to $3.0 million in 2024, then increased by 11.58% to $3.4 million in 2025.
  • The last three reported values for Goodwill were $3.4 million (Q4 2025), $3.4 million (Q3 2025), and $3.4 million (Q2 2025) per Business Quant data.